Amgen Inc AMGN Prévision boursière
Prédiction de prix et analyse propulsées par l'IA pour Amgen Inc · Mise à jour Jul 24, 2026
Prévision IA à 90 jours
ACHETER
7 jours
30 jours
90 jours
Confiance de l'IA: -10% Corrélation de Spearman
juillet 24, 2026
Voir l'objectif de prix exact de AMGN
Créez un compte gratuit et suivez cette action pour débloquer ses prévisions IA complètes — 3 actions gratuites.
Inscrivez-vous gratuitement avec Google✓ Compte gratuit · ✓ Essai de 30 jours · ✓ Annuler à tout moment
Graphique des prix
Chargement du graphique...
Statistiques clés
Capitalisation boursière
$200.50B
Ratio P/E
25,7x
Ratio P/B
21,82x
Rend. dividende
2,60%
BPA
$8,92
ROE
99,6%
Marge nette
32,6%
Chiffre d'affaires
$37B
Ratio de liquidité générale
1,26x
À propos de Amgen Inc
Amgen Inc (AMGN) opère dans le secteur Life Sciences, spécifiquement dans le secteur Biological Products, (No Diagnostic Substances). .
Dernières actualités
Biological Products, (No Diagnostic Substances) Entreprises comparables
| Entreprise | Ticker | Signal IA | Capitalisation boursière | P/E |
|---|---|---|---|---|
| Acumen Pharmaceuticals, Inc. | ABOS | ██% | $157M | -x |
| Abpro Holdings, Inc. | ABPO | ██% | $1M | -x |
| Alpha Cognition Inc. | ACOG | ██% | $179M | -x |
| Adaptimmune Therapeutics Plc | ADAPY | ██% | $8M | -x |
| Adma Biologics, Inc. | ADMA | ██% | $1.94B | 11,8x |
| Adaptive Biotechnologies Corp | ADPT | ██% | $3.56B | -x |
| Agenus Inc | AGEN | ██% | $238M | 3,7x |
| Agentix Corp. | AGTX | ██% | $800K | -x |
| Aim Immunotech Inc. | AIM | ██% | $7M | -x |
| Alector, Inc. | ALEC | ██% | $165M | -x |
| Aligos Therapeutics, Inc. | ALGS | ██% | $29M | -x |
| Allogene Therapeutics, Inc. | ALLO | ██% | $628M | -x |
| Alvotech | ALVO | ██% | $992M | -x |
| Amgen Inc | AMGN | ██% | $200.50B | 25,7x |
| Apogee Therapeutics, Inc. | APGE | ██% | $10.05B | -x |
| Aptose Biosciences Inc. | APTOF | ██% | $4M | -x |
| Argenx Se | ARGX | ██% | $57.22B | -x |
| Armata Pharmaceuticals, Inc. | ARMP | ██% | $192M | -x |
| Artiva Biotherapeutics, Inc. | ARTV | ██% | $492M | -x |
| Atara Biotherapeutics, Inc. | ATRA | ██% | $70M | -x |
| Atyr Pharma Inc | ATYR | ██% | $49M | -x |
| Aura Biosciences, Inc. | AURA | ██% | $745M | -x |
| Autolus Therapeutics Plc | AUTL | ██% | $405M | -x |
| Anavex Life Sciences … | AVXL | ██% | $230M | -x |
| Bioatla, Inc. | BCAB | ██% | $6M | -x |
| Biocardia, Inc. | BCDA | ██% | $14M | -x |
| Brainstorm Cell Therapeutics … | BCLI | ██% | $11M | -x |
| Biocryst Pharmaceuticals Inc | BCRX | ██% | $2.38B | -x |
| Black Diamond Therapeutics, … | BDTX | ██% | $105M | -x |
| Beam Therapeutics Inc. | BEAM | ██% | $2.66B | -x |
| Biogen Inc. | BIIB | ██% | $29.53B | 21,5x |
| Biontech Se | BNTX | ██% | $23.28B | -x |
| Cabaletta Bio, Inc. | CABA | ██% | $444M | -x |
| Candel Therapeutics, Inc. | CADL | ██% | $722M | -x |
| C4 Therapeutics, Inc. | CCCC | ██% | $380M | -x |
| Creative Medical Technology … | CELZ | ██% | $5M | -x |
| Cero Therapeutics Holdings, … | CERO | ██% | $500K | -x |
| Cullinan Therapeutics, Inc. | CGEM | ██% | $1.06B | -x |
| Compugen Ltd | CGEN | ██% | $221M | 3,1x |
| Cg Oncology, Inc. | CGON | ██% | $6.26B | -x |
| Cognition Therapeutics Inc | CGTX | ██% | $86M | -x |
| Coherus Oncology, Inc. | CHRS | ██% | $221M | 1,2x |
| Calidi Biotherapeutics, Inc. | CLDI | ██% | $2M | -x |
| Cellectis S.A. | CLLS | ██% | $279M | -x |
| Compass Therapeutics, Inc. | CMPX | ██% | $382M | -x |
| Mosaic Immunoengineering Inc. | CPMV | ██% | $5M | -x |
| Cardiff Oncology, Inc. | CRDF | ██% | $65M | -x |
| Cardiol Therapeutics Inc. | CRDL | ██% | $123M | -x |
| Curis Inc | CRIS | ██% | $9M | -x |
| Crispr Therapeutics Ag | CRSP | ██% | $4.58B | -x |
| Champions Oncology, Inc. | CSBR | ██% | $83M | -x |
| Cel Sci Corp | CVM | ██% | $21M | -x |
| Dbv Technologies S.A. | DBVT | ██% | $820M | -x |
| Ginkgo Bioworks Holdings, … | DNA | ██% | $489M | -x |
| Denali Therapeutics Inc. | DNLI | ██% | $3.72B | -x |
| Precision Biosciences Inc | DTIL | ██% | $189M | -x |
| Dyadic International Inc | DYAI | ██% | $44M | -x |
| Editas Medicine, Inc. | EDIT | ██% | $419M | -x |
| Elutia Inc. | ELUT | ██% | $40M | 0,8x |
| Engene Therapeutics Inc. | ENGN | ██% | $127M | -x |
| Entera Bio Ltd. | ENTX | ██% | $99M | -x |
| Viskase Holdings, Inc. | ENZN | ██% | $59M | -x |
| Estrella Immunopharma, Inc. | ESLA | ██% | $32M | -x |
| Evaxion A/S | EVAX | ██% | $25M | -x |
| Exelixis, Inc. | EXEL | ██% | $14.12B | 16,9x |
| Exozymes Inc. | EXOZ | ██% | $40M | -x |
| Fate Therapeutics Inc | FATE | ██% | $293M | -x |
| 4d Molecular Therapeutics, … | FDMT | ██% | $543M | -x |
| Fennec Pharmaceuticals Inc. | FENC | ██% | $351M | -x |
| Gilead Sciences, Inc. | GILD | ██% | $162.53B | 17,6x |
| Monte Rosa Therapeutics, … | GLUE | ██% | $1.94B | -x |
| Genenta Science S.P.A. | GNTA | ██% | $80M | -x |
| Green Planet Bio … | GPLB | ██% | $260K | -x |
| Greenland Mines Ltd | GRML | ██% | $30M | -x |
| Halozyme Therapeutics, Inc. | HALO | ██% | $9.58B | 27,5x |
| Humacyte, Inc. | HUMA | ██% | $172M | -x |
| Immunitybio, Inc. | IBRX | ██% | $7.75B | -x |
| Inhibikase Therapeutics, Inc. | IKT | ██% | $366M | -x |
| Imagenebio, Inc. | IMA | ██% | $63M | -x |
| Immunocore Holdings Plc | IMCR | ██% | $1.81B | -x |
| Immatics N.V. | IMTX | ██% | $1.25B | -x |
| Immunovant, Inc. | IMVT | ██% | $8.03B | -x |
| In8bio, Inc. | INAB | ██% | $12M | -x |
| Mink Therapeutics, Inc. | INKT | ██% | $50M | -x |
| Inmune Bio, Inc. | INMB | ██% | $46M | -x |
| Intensity Therapeutics, Inc. | INTS | ██% | $11M | -x |
| Iovance Biotherapeutics, Inc. | IOVA | ██% | $2.25B | -x |
| Century Therapeutics, Inc. | IPSC | ██% | $391M | -x |
| Invivyd, Inc. | IVVD | ██% | $172M | -x |
| Zura Bio Ltd | JATT | ██% | $88M | -x |
| Jasper Therapeutics, Inc. | JSPR | ██% | $24M | -x |
| Kalaris Therapeutics, Inc. | KLRS | ██% | $90M | -x |
| Kodiak Sciences Inc. | KOD | ██% | $2.55B | -x |
| Krystal Biotech, Inc. | KRYS | ██% | $9.64B | 42,8x |
| Kymera Therapeutics, Inc. | KYMR | ██% | $9.07B | -x |
| Kyverna Therapeutics, Inc. | KYTX | ██% | $441M | -x |
| Lineage Cell Therapeutics, … | LCTX | ██% | $267M | -x |
| Lenz Therapeutics, Inc. | LENZ | ██% | $158M | -x |
| Atyr Pharma Inc | LIFE | ██% | $1.87B | -x |
| Liminatus Pharma, Inc. | LIMN | ██% | $7M | -x |
| Leonabio, Inc. | LONA | ██% | $68M | -x |
| Lexeo Therapeutics, Inc. | LXEO | ██% | $349M | -x |
| Maze Therapeutics, Inc. | MAZE | ██% | $1.53B | -x |
| Mesoblast Ltd | MESO | ██% | $2.09B | -x |
| Meiragtx Holdings Plc | MGTX | ██% | $986M | -x |
| Metagenomi Therapeutics, Inc. | MGX | ██% | $46M | -x |
| Molecular Partners Ag | MOLN | ██% | $160M | -x |
| Moderna, Inc. | MRNA | ██% | $22.64B | -x |
| Neurocrine Biosciences Inc | NBIX | ██% | $17.52B | 26,2x |
| Neumora Therapeutics, Inc. | NMRA | ██% | $281M | -x |
| Novavax Inc | NVAX | ██% | $1.29B | -x |
| Ocugen, Inc. | OCGN | ██% | $430M | -x |
| Outlook Therapeutics, Inc. | OTLK | ██% | $247M | -x |
| Palisade Bio, Inc. | PALI | ██% | $338M | -x |
| Passage Bio, Inc. | PASG | ██% | $16M | -x |
| Vaxcyte, Inc. | PCVX | ██% | $8.03B | -x |
| Biomx Inc. | PHGE | ██% | $2M | -x |
| Pluri Inc. | PLUR | ██% | $19M | -x |
| Protalix Biotherapeutics, Inc. | PLX | ██% | $189M | 12,3x |
| Pharmacyte Biotech, Inc. | PMCB | ██% | $6M | -x |
| Prime Medicine, Inc. | PRME | ██% | $536M | -x |
| Prokidney Corp. | PROK | ██% | $459M | -x |
| Pelthos Therapeutics Inc. | PTHS | ██% | $96M | -x |
| Qiagen N.V. | QGEN | ██% | $8.99B | -x |
| Quince Therapeutics, Inc. | QNCX | ██% | $18M | 2,1x |
| Replimune Group, Inc. | REPL | ██% | $865M | -x |
| Repligen Corp | RGEN | ██% | $7.76B | 151,0x |
| Regenxbio Inc. | RGNX | ██% | $656M | -x |
| Relay Therapeutics, Inc. | RLAY | ██% | $4.16B | -x |
| Revolution Medicines, Inc. | RVMD | ██% | $37.78B | -x |
| Recursion Pharmaceuticals, Inc. | RXRX | ██% | $1.60B | -x |
| Sab Biotherapeutics, Inc. | SABS | ██% | $274M | -x |
| Sana Biotechnology, Inc. | SANA | ██% | $866M | -x |
| Scilex Holding Co | SCLX | ██% | $52M | -x |
| Scinai Immunotherapeutics Ltd. | SCNI | ██% | $1M | -x |
| Sangamo Therapeutics, Inc | SGMO | ██% | $29M | -x |
| Sangamo Therapeutics, Inc | SGMOQ | ██% | $27M | -x |
| Solid Biosciences Inc. | SLDB | ██% | $804M | -x |
| Silexion Therapeutics Corp | SLXN | ██% | $3M | -x |
| Senti Biosciences Holdings, … | SNTI | ██% | $13M | -x |
| Scholar Rock Holding … | SRRK | ██% | $5.89B | -x |
| Surrozen, Inc./De | SRZN | ██% | $243M | -x |
| Sutro Biopharma, Inc. | STRO | ██% | $391M | -x |
| Protara Therapeutics, Inc. | TARA | ██% | $226M | -x |
| Tarsus Pharmaceuticals, Inc. | TARS | ██% | $2.52B | -x |
| Tscan Therapeutics, Inc. | TCRX | ██% | $55M | -x |
| Bio-Techne Corp | TECH | ██% | $11.23B | 102,5x |
| Tectonic Therapeutic, Inc. | TECX | ██% | $595M | -x |
| Instil Bio, Inc. | TIL | ██% | $49M | -x |
| Tenaya Therapeutics, Inc. | TNYA | ██% | $168M | -x |
| Taysha Gene Therapies, … | TSHA | ██% | $1.67B | -x |
| Tevogen Bio Holdings … | TVGN | ██% | $18M | -x |
| Twist Bioscience Corp | TWST | ██% | $5.75B | -x |
| Voyager Acquisition Corp./Cayman … | VACH | ██% | $541M | 80,4x |
| Valneva Se | VALN | ██% | $488M | -x |
| Vericel Corp | VCEL | ██% | $2.30B | 107,1x |
| Vir Biotechnology, Inc. | VIR | ██% | $1.51B | -x |
| Vivosim Labs, Inc. | VIVS | ██% | $2M | -x |
| Vor Biopharma Inc. | VOR | ██% | $1.03B | -x |
| Vaxart, Inc. | VXRT | ██% | $121M | 3,3x |
| Voyager Therapeutics, Inc. | VYGR | ██% | $186M | -x |
| Windtree Therapeutics Inc … | WINT | ██% | $340K | -x |
| X4 Pharmaceuticals, Inc | XFOR | ██% | $376M | -x |
| Zeo Scientifix, Inc. | ZEOX | ██% | $14M | -x |
| Zivo Bioscience, Inc. | ZIVO | ██% | $19M | -x |
| Zura Bio Ltd | ZURA | ██% | $502M | -x |
FAQ
-
Amgen Inc est-il une bonne action à acheter ?
Notre IA analyse Amgen Inc quotidiennement. Consultez le signal ci-dessus pour la dernière recommandation. Effectuez toujours vos propres recherches avant d'investir.
-
Quelle est la précision des prédictions de Amgen Inc ?
Notre IA atteint une corrélation de Spearman de -10% pour cette action, avec une précision moyenne supérieure à 67% sur plus de 4 000 actions analysées quotidiennement.
-
À quelle fréquence les prévisions sont-elles mises à jour ?
Les prévisions de Amgen Inc sont mises à jour quotidiennement avec les dernières données de marché et les modèles d'IA.
Prêt à investir plus intelligemment ?
Rejoignez des milliers d'investisseurs utilisant des prédictions boursières propulsées par l'IA
Inscription gratuite✓ Compte gratuit · ✓ Plus de 4 000 actions · ✓ Mises à jour quotidiennes
Vous cherchez une analyse plus approfondie de Amgen Inc ?
Voir l'analyse institutionnelle complète sur Intratio →Les prédictions IA sont basées sur des modèles historiques et ne doivent pas constituer la seule base pour les décisions d'investissement. Les performances passées ne garantissent pas les résultats futurs. Effectuez toujours vos propres recherches.